NCT03742817

Brief Summary

This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal across young adult e-cigarette users and middle-age/older adult smokers with an interest in, but no significant experience with, e-cigarettes; (2) Determine which dimensions of e-cigarette product diversity differentially affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers with an interest in, but no significant experience with, e-cigarettes; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For Aim 1, young adult vapers (N=200) and adult smokers (N=200) will attend one laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, pg/vg ratio). For Aim 2, young adults vapers (N=360) and adult smokers (N=360) will administer an e-cigarette product and complete behavioral economic tasks that test the participant's choice of earning money to delay initiation and continued use of: (1) The sampled e-cigarette product (abuse liability; young adult vapers); or (2) Their own brand cigarettes (ability to resist smoking; adult current smokers). A pilot study will establish device and e-liquid parameters (e.g., nicotine concentration) to be used for all aims.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 15, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

July 11, 2023

Status Verified

July 1, 2023

Enrollment Period

1.1 years

First QC Date

November 14, 2018

Last Update Submit

July 7, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Subjective Appeal

    Self-report measures of product appeal will be completed following the e-cigarette administration.

    1 hour

  • Positive Affect Negative Affect Schedule

    The 10-item Positive Affect Negative Affect Schedule (PANAS-SF) will be used to measure positive and negative affect.

    4 hours

  • Questionnaire of Vaping Urges

    10-item Brief Questionnaire of Vaping Urges will assess desire, intention, urge and need to vape e-cigarettes.

    4 hours

Study Arms (4)

Sweet-Flavor 4.5% Nicotine (Salt)

EXPERIMENTAL

Participants will self-administer a sweet-flavored e-cigarette containing 4.5% nicotine by volume.

Other: e-Cigarette

Sweet-Flavor 0 mg/mL Nicotine (Free-Base)

PLACEBO COMPARATOR

Participants will self-administer a sweet-flavored e-cigarette containing 0 mg/mL nicotine.

Other: e-Cigarette

Sweet-Flavor 6 mg/mL Nicotine (Free-Base)

EXPERIMENTAL

Participants will self-administer a sweet-flavored e-cigarette containing 6 mg/mL nicotine.

Other: e-Cigarette

Usual e-Cigarette

ACTIVE COMPARATOR

Participants will self-administer either their preferred brand combustible cigarette or e-cigarette with usual nicotine nicotine concentration.

Other: e-Cigarette

Interventions

Participants will self-administer an experimenter-provided e-cigarette.

Sweet-Flavor 0 mg/mL Nicotine (Free-Base)Sweet-Flavor 4.5% Nicotine (Salt)Sweet-Flavor 6 mg/mL Nicotine (Free-Base)Usual e-Cigarette

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Vapers
  • E-cigarette use \>3 day/week for \>2 months
  • Report regularly using e-cigarette products with nicotine
  • Positive cotinine test via NicAlert test strip
  • Smokers
  • Daily cigarette smoking for ≥ 2 years
  • Currently smoke \> 4 cig/day
  • Interest in trying an e-cigarette or current use of e-cigarettes

You may not qualify if:

  • Vapers
  • Pregnancy/breastfeeding
  • Desire to immediately reduce e-cigarette use
  • Smokers
  • Breath CO \< 9ppm at intake
  • Pregnancy / breastfeeding
  • Current daily use of other combustible tobacco products (e.g., cigars)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Southern California

Los Angeles, California, 90033, United States

Location

Related Publications (1)

  • Han DH, Wong M, Peraza N, Vogel EA, Cahn R, Mason TB, Kirkpatrick M, Tackett AP, Leventhal AM. Dose-response effects of two nicotine salt formulations on electronic cigarette appeal and sensory attributes. Tob Control. 2023 Jan 2:tobaccocontrol-2022-057553. doi: 10.1136/tc-2022-057553. Online ahead of print.

MeSH Terms

Conditions

Vaping

Interventions

Electronic Nicotine Delivery Systems

Condition Hierarchy (Ancestors)

SmokingBehavior

Intervention Hierarchy (Ancestors)

Smoking DevicesManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Adam M Leventhal, PhD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Preventive Medicine

Study Record Dates

First Submitted

November 14, 2018

First Posted

November 15, 2018

Study Start

February 1, 2019

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

July 11, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations